Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemzar study in HIV-associated Kaposi's sarcoma
PACTR201510001143243Recruiting
- Sponsor
- AMPATH Oncology Institute
- Start
- May 2014
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of gemcitabine, bleomycin and vincristine in Kaposi sarcoma (KS) (2 arms), sponsored by AMPATH Oncology Institute. Started May 2014; status: recruiting.
02
Drugs
gemcitabinebleomycinvincristine
03
Conditions
Kaposi sarcoma (KS)
Beyond the preview
Go deeper on PACTR201510001143243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201510001143243.